SHENZHEN TECHDOW
GenericsSHENZHEN TECHDOW is a generic drug manufacturer focused on Cardiovascular, Respiratory.
SHENZHEN TECHDOW's Key Drugs
SHENZHEN TECHDOW's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SHENZHEN TECHDOW's Recent FDA Approvals
New NDA/BLA approvals for SHENZHEN TECHDOW over the last two years — novel drugs only, excluding generics and label supplements.
SHENZHEN TECHDOW's Therapeutic Areas
SHENZHEN TECHDOW's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Respiratory, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SHENZHEN TECHDOW's Top Competitors
SHENZHEN TECHDOW's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Bayer. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SHENZHEN TECHDOW Pipeline Snapshot
Active clinical trials for SHENZHEN TECHDOW across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2014-06-12
- Latest
- 2025-11-25
- Applications
- 5